EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
(Book)
Description
Also in this Series
Copies
| Volume | Location | Call Number | Status |
|---|---|---|---|
| 2016 | Middletown-Thrall Public Library District - Gov't Document Monograph | Y 4.L 11/4:S.HRG.114-805 2016 | On Shelf |
More Details
Notes
Citations
United States. Congress. Senate. Committee on Health, E. (2018). EpiPen price increases: how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY) . U.S. Government Publishing Office.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. 2018. EpiPen Price Increases: How Regulatory Barriers Inhibit Pharmaceutical Competition : Field Hearing of the Subcommittee On Children and Families of the Committee On Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, Second Session On Examining EpiPen Price Increases, Focusing On How Regulatory Barriers Inhibit Pharmaceutical Competition, October 7, 2016 (Lexington, KY). U.S. Government Publishing Office.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. EpiPen Price Increases: How Regulatory Barriers Inhibit Pharmaceutical Competition : Field Hearing of the Subcommittee On Children and Families of the Committee On Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, Second Session On Examining EpiPen Price Increases, Focusing On How Regulatory Barriers Inhibit Pharmaceutical Competition, October 7, 2016 (Lexington, KY) U.S. Government Publishing Office, 2018.
MLA Citation, 9th Edition (style guide)United States. Congress. Senate. Committee on Health, Education. EpiPen Price Increases: How Regulatory Barriers Inhibit Pharmaceutical Competition : Field Hearing of the Subcommittee On Children and Families of the Committee On Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, Second Session On Examining EpiPen Price Increases, Focusing On How Regulatory Barriers Inhibit Pharmaceutical Competition, October 7, 2016 (Lexington, KY) U.S. Government Publishing Office, 2018.